Medicare Enrolled
Dr. Jolly Varki, MD
Hematology & Oncology · Miami, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Varki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Varki? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Varki
Dr. Jolly Varki is a hematology & oncology in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Varki performed 8,731 Medicare services across 501 unique beneficiaries.
Between the years covered by Open Payments, Dr. Varki received a total of $30,734 from 86 pharmaceutical and/or device companies across 1362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Varki is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 27% volume in FL$ $30,734 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,731
Medicare services
Top 27% in FL for hematology & oncology
501
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~437 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (ondansetron/Zofran) | 3,200 | $0 | $15 |
| Dexamethasone injection (steroid) | 2,072 | $0 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 777 | $23 | $91 |
| Complete blood count (CBC) with differential | 590 | $8 | $34 |
| Blood draw (venipuncture) | 588 | $8 | $18 |
| Office visit, established patient (30-39 min) | 328 | $104 | $411 |
| Injection, diphenhydramine hcl, up to 50 mg | 316 | $1 | $10 |
| Administration of chemotherapy into vein, each additional hour | 306 | $23 | $90 |
| Administration of chemotherapy into vein, 1 hour or less | 214 | $107 | $416 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 130 | $53 | $205 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 71 | $28 | $108 |
| Drug injection, under skin or into muscle | 70 | $11 | $45 |
| Administration of additional new drug or substance into vein, 1 hour or less | 50 | $54 | $206 |
| New patient office visit (45-59 min) | 19 | $131 | $543 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.4% high complexity
71.6% medium
18.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$30,734
Total received (2018-2024)
Avg $4,391/year across 7 years
Top 20% in FL for hematology & oncology
86
Companies
1,362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,911 (90.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,809 (5.9%)
Other
Charitable contributions, space rental, and other categories
$1,014 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,556
2023$5,468
2022$4,666
2021$3,647
2020$2,832
2019$4,249
2018$4,317
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,218
Novartis Pharmaceuticals Corporation
$3,095
Janssen Biotech, Inc.
$2,780
PFIZER INC.
$2,314
Celgene Corporation
$1,599
Astellas Pharma US Inc
$1,568
E.R. Squibb & Sons, L.L.C.
$1,417
Amgen Inc.
$974
Merck Sharp & Dohme Corporation
$925
Merck Sharp & Dohme LLC
$755
Incyte Corporation
$642
BeiGene USA, Inc.
$523
Seagen Inc.
$522
Exelixis Inc.
$522
Lilly USA, LLC
$479
Rigel Pharmaceuticals, Inc.
$465
Daiichi Sankyo Inc.
$436
EMD Serono, Inc.
$434
Genentech USA, Inc.
$430
Eisai Inc.
$427
Gilead Sciences, Inc.
$396
Bayer HealthCare Pharmaceuticals Inc.
$359
GENZYME CORPORATION
$356
Ipsen Biopharmaceuticals, Inc
$331
Myovant Sciences Inc.
$314
NOVARTIS PHARMACEUTICALS CORPORATION
$276
ARRAY BIOPHARMA INC
$214
Coherus Biosciences Inc.
$207
Karyopharm Therapeutics Inc.
$201
Seattle Genetics, Inc.
$195
Bayer Healthcare Pharmaceuticals Inc.
$193
Sumitomo Pharma America, Inc.
$181
Kite Pharma, Inc.
$178
Takeda Pharmaceuticals U.S.A., Inc.
$172
ABBVIE INC.
$171
Clovis Oncology, Inc.
$168
TOLMAR Pharmaceuticals, Inc.
$166
Janssen Pharmaceuticals, Inc
$152
Regeneron Healthcare Solutions, Inc.
$147
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
MEDIVATION FIELD SOLUTIONS LLC
$136
Epizyme, Inc.,
$134
Tolmar, Inc.
$133
GlaxoSmithKline, LLC.
$131
Mirati Therapeutics, Inc.
$129
Taiho Oncology, Inc.
$125
Array BioPharma Inc.
$122
Mylan Institutional Inc.
$105
Pharmacyclics LLC, An AbbVie Company
$103
Janssen Products, LP
$100
ADC Therapeutics America, Inc.
$93
JAZZ PHARMACEUTICALS INC.
$82
Kyowa Kirin, Inc.
$82
Sun Pharmaceutical Industries Inc.
$75
AVEO Pharmaceuticals, Inc.
$74
EISAI INC.
$72
Spectrum Pharmaceuticals Inc.
$70
Verastem, Inc.
$53
TESARO, Inc.
$53
Organon LLC
$51
Deciphera Pharmaceuticals Inc.
$47
AbbVie, Inc.
$43
AbbVie Inc.
$43
Puma Biotechnology, Inc.
$42
Myriad Genetic Laboratories, Inc.
$42
Pharmacosmos Therapeutics Inc.
$40
Genmab U.S., Inc.
$40
Dova Pharmaceuticals
$38
CTI BioPharma Corp.
$38
Stemline Therapeutics Inc.
$38
PUMA BIOTECHNOLOGY, INC.
$37
Ethicon US, LLC
$35
pharmaand GmbH
$26
TAIHO ONCOLOGY, INC.
$25
MorphoSys, US Inc.
$24
Tempus AI, Inc
$24
SOBI, INC
$23
Amneal Pharmaceuticals LLC
$23
Pharmacyclics LLC, an AbbVie Company
$22
SANOFI-AVENTIS U.S. LLC
$22
Alexion Pharmaceuticals, Inc.
$19
Midatech Pharma US Inc
$18
Jazz Pharmaceuticals Inc.
$17
Boston Scientific Corporation
$16
Teva Pharmaceuticals USA, Inc.
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Top 3 companies account for 29.6% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · AVASTIN · Abraxane · Alecensa · Aliqopa · Aranesp · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FOTIVDA · Folotyn · Fulphila · GAZYVA · GILOTRIF · Gelclair · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · IRESSA · Imbruvica · Inrebic · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TUKYSA · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $352 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
179
Per 100K population
6.7
County median income
$68,694
Nearest hospital
MIAMI VA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Varki is a mixed practice specialist, with above-average Medicare volume (top 27% in FL), and high industry engagement (low-engagement, top 20%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Varki experienced with anti-nausea injection (ondansetron/zofran)?
Based on Medicare claims data, Dr. Varki performed 3,200 anti-nausea injection (ondansetron/zofran) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Varki receive payments from pharmaceutical companies?
Yes. Dr. Varki received a total of $30,734 from 86 companies across 1,362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Varki's costs compare to other hematology & oncologys in Miami?
Dr. Varki's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Varki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Miami
Browse hematology & oncologys in Miami ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology